Publications by authors named "K Sugio"
Article Synopsis
- The study investigates the R-CHADS-VASc score's ability to predict cardiovascular events in atrial fibrillation (AF) patients post bioprosthetic valve replacement, using data from the BPV-AF registry with 766 participants.
- Patients were classified into low, moderate, and high risk based on their R-CHADS-VASc scores, with results indicating that those with higher scores experienced significantly more cardiovascular events during the follow-up period.
- The findings suggest that the R-CHADS-VASc score is an effective tool for assessing cardiovascular risk in AF patients who have undergone BPV replacement, with higher scores correlating to worse outcomes.
Article Synopsis
- Current guidelines suggest using either DOACs or warfarin for patients with atrial fibrillation who have a bioprosthetic valve, but research on elderly patients (≥80 years) in this context is limited.
- A study analyzed data from 752 patients, revealing that those aged ≥80 had a significantly higher risk of adverse outcomes than younger patients, with a hazard ratio of 2.04.
- The findings indicate that both DOACs and warfarin have comparable efficacy and safety in managing elderly patients with bioprosthetic valves and atrial fibrillation.
Background: Based on the results of JCOG0802 and CALGB studies, segmentectomy has considered to be a standard procedure for early-stage non-small cell lung cancer (NSCLC). After lobectomy, the residual cavity is filled with mediastinal and diaphragmatic deviations, and compensatory volume changes are present in the residual lungs. In this study, we examined the efficacy of segmentectomy, a surgical procedure, by focusing on its impact on postoperative lung volume and function.
View Article and Find Full Text PDFThe patient was a 74-year-old woman who was diagnosed with lung adenocarcinoma, clinical Stage IIIA. Induction chemoradiation was performed followed by right upper lobectomy and lymph node dissection. Because of positive pleural effusion cytology, which was proven after surgery, the patient was diagnosed with pathological Stage IVA with EGFR L858R mutation.
View Article and Find Full Text PDF